Presence of commensal house dust mite allergen in human gastrointestinal tract: A potential contributor to intestinal barrier dysfunction

Gut

Volumn 65, Issue 5, 2016, Pages 757-766

  Tulic, Meri K ^a,b   Vivinus Nébot, Mylene ^a,c   Rekima, Akila ^a   Medeiros, Samara Rabelo ^a,d   Bonnart, Chrystelle ^d,e,g   Shi, Haining ^h   Walker, Allan ^h   Dainese, Raffaella ^a,c   Boyer, Julien ^a,c   Vergnolle, Nathalie ^e,f,g   Piche, Thierry ^a,c   Verhasselt, Valérie ^a,b  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b Worldwide Universities Network   (United Kingdom)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^d FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^e INSERM   (France)

^f CNRS   (France)

^g UNIVERSITÉ PAUL SABATIER   (France)

^h MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE; HOUSE DUST ALLERGEN; INTERLEUKIN 10; MUCIN; TIGHT JUNCTION PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ARTICLE; COLON BIOPSY; COMMENSAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DERMATOPHAGOIDES PTERONYSSINUS; DISEASE SEVERITY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES ANALYSIS; GASTROINTESTINAL DISEASE; GASTROINTESTINAL TRACT; HUMAN; IN VIVO STUDY; INTESTINAL BARRIER DYSFUNCTION; INTESTINE MUCOSA PERMEABILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH2 CELL; ANIMAL; BAGG ALBINO MOUSE; IMMUNOLOGY; ISOLATION AND PURIFICATION;

ANIMALS; ANTIGENS, DERMATOPHAGOIDES; DERMATOPHAGOIDES PTERONYSSINUS; GASTROINTESTINAL DISEASES; GASTROINTESTINAL TRACT; HUMANS; MICE; MICE, INBRED BALB C;

EID: 84954286645     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2015-310523     Document Type: Article

References (42)

1. Pastorelli L, De Salvo C, Mercado JR, et al. Central role of the gut epithelial barrier in the pathogenesis of chronic intestinal inflammation: lessons learned from animal models and human genetics. Frontiers Immunol 2013;4:280.
2. Maloy KJ, Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011;474:298-306.
3. Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol 2009;124; 3-20; quiz 21-22.
4. Geremia A, Biancheri P, Allan P, et al. Innate and adaptive immunity in inflammatory bowel disease. Autoimmunity Rev 2014;13:3-10.
5. Verhasselt V. Oral tolerance in neonates: from basics to potential prevention of allergic disease. Muc Immunol 2010;3:326-33.
6. Faria AM, Weiner HL. Oral tolerance. Imm Rev 2005;206:232-59.
7. Pabst O, Mowat AM. Oral tolerance to food protein. Muc Immunol 2012;5:232-9.
8. Sporik R, Chapman MD, Platts-Mills TA. House dust mite exposure as a cause of asthma. Clin Exp Allergy 1992;22:897-906.
9. Gough L, Schulz O, Sewell HF, et al. The cysteine protease activity of the major dust mite allergen der p 1 selectively enhances the immunoglobulin E antibody response. J Exp Med 1999;190:1897-902.
10. Wan H, Winton HL, Soeller C, et al. der p 1 facilitates transepithelial allergen delivery by disruption of tight junctions. J Clin Invest 1999;104:123-33.
11. Asokananthan N, Graham PT, Stewart DJ, et al. House dust mite allergens induce proinflammatory cytokines from respiratory epithelial cells: the cysteine protease allergen, der p 1, activates protease-activated receptor (PAR)-2 and inactivates PAR-1. J Immunol 2002;169; 4572-8.
12. Akdis CA, Akdis M. Mechanisms of immune tolerance to allergens: role of IL-10 and Tregs. J Clin Invest 2014;124:4678-80.
13. Akdis M, Verhagen J, Taylor A, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004;199:1567-75.
14. Bueno L, Fioramonti J. Protease-activated receptor 2 and gut permeability: a review. Neurogastroenterol Motil 2008;20:580-7.
15. Piche T, Barbara G, Aubert P, et al. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators. Gut 2009;58:196-201.
16. Turk B. Targeting proteases: successes, failures and future prospects. Nat Rev Drug Disc 2006;5:785-99.
17. Van Itallie CM, Anderson JM. Claudins and epithelial paracellular transport. Ann Review Physiol 2006;68:403-29..
18. Vergnolle N. Protease-activated receptors as drug targets in inflammation and pain. Pharmacol Therap 2009;123:292-309.
19. Annahazi A, Ferrier L, Bézirard V, et al. Luminal cysteine-proteases degrade colonic tight junction structure and are responsible for abdominal pain in constipation-predominant IBS. Am J Gastroenterol 2013;108:1322-31.
20. Roka R, Rosztóczy A, Leveque M, et al. A pilot study of fecal serine-protease activity: a pathophysiologic factor in diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2007;5:550-5.
21. Hyun E, Andrade-Gordon P, Steinhoff M, et al. Protease-activated receptor-2 activation: a major actor in intestinal inflammation. Gut 2008;57:1222-9.
22. Lohman RJ, Cotterell AJ, Suen J, et al. Antagonism of protease-activated receptor 2 protects against experimental colitis. J Pharmacol Exp Therap 2012;340:256-65.
23. Willoughby JB, Willoughby WF. In vivo responses to inhaled proteins. I. Quantitative analysis of antigen uptake, fate, and immunogenicity in a rabbit model system. J Immunol 1977;119:2137-46.
24. Calabrese EJ, Stanek EJ III, Pekow P, et al. Soil ingestion estimates for children residing on a superfund site. Ecotoxicol Environ Safety 1997;36:258-68.
25. Macchiaverni P, Rekima A, Turfkruyer M, et al. Respiratory allergen from house dust mite is present in human milk and primes for allergic sensitization in a mouse model of asthma. Allergy 2014;69:395-8.
26. Sakamoto K, Hirose H, Onizuka A, et al. Quantitative study of changes in intestinal morphology and mucus gel on total parenteral nutrition in rats. J Surg Res 2000;94:99-106.
27. Cho HJ, Lee HJ, Kim SC, et al. Protease-activated receptor 2-dependent fluid secretion from airway submucosal glands by house dust mite extract. J Allergy Clin Immunol 2012;129:529-35.
28. Van Der Post S, Subramani DB, Backstrom M, et al. Site-specific O-glycosylation on the MUC2 mucin protein inhibits cleavage by the Porphyromonas gingivalis secreted cysteine protease (RgpB). J Biol Chem 2013;288:14636-46.
29. Comoy EE, Pestel J, Duez C, et al. The house dust mite allergen, Dermatophagoides pteronyssinus, promotes type 2 responses by modulating the balance between IL-4 and IFN-gamma. J Immunol 1998;160:2456-62.
30. Kalsheker NA, Deam S, Chambers L, et al. The house dust mite allergen der p1 catalytically inactivates alpha 1-antitrypsin by specific reactive centre loop cleavage: a mechanism that promotes airway inflammation and asthma. Biochem Biophys Res Comm 1996;221:59-61.
31. Schulz O, Sewell HF, Shakib F. A sensitive fluorescent assay for measuring the cysteine protease activity of der p 1, a major allergen from the dust mite Dermatophagoides pteronyssinus. Mol Pathol 1998;51:222-4.
32. Zeissig S, Bojarski C, Buergel N, et al. Downregulation of epithelial apoptosis and barrier repair in active Crohn's disease by tumour necrosis factor alpha antibody treatment. Gut 2004;53:1295-302.
33. Lehker MW, Sweeney D. Trichomonad invasion of the mucous layer requires adhesins, mucinases, and motility. Sex Trans Inf 1999;75:231-8.
34. Lidell ME, Moncada DM, Chadee K, et al. Entamoeba histolytica cysteine proteases cleave the MUC2 mucin in its C-terminal domain and dissolve the protective colonic mucus gel. PNAS 2006;103:9298-303.
35. Keely S, Hansbro PM. Lung-gut cross talk: a potential mechanism for intestinal dysfunction in patients with COPD. Chest 2014;145:199-200.
36. Trompette A, Gollwitzer ES, Yadava K, et al. Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 2014;20:159-66.
37. Wang H, Liu JS, Peng SH, et al. Gut-lung crosstalk in pulmonary involvement with inflammatory bowel diseases. World J Gastroenterol 2013;19:6794-804.
38. Bannert C, Bidmon-Fliegenschnee B, Stary G, et al. Fc-epsilon-RI, the high affinity IgE-receptor, is robustly expressed in the upper gastrointestinal tract and modulated by mucosal inflammation. PLoS ONE 2012;7:e42066.
39. Vivinus-Nebot M, Dainese R, Anty R, et al. Combination of allergic factors can worsen diarrheic irritable bowel syndrome: role of barrier defects and mast cells. Am J Gastroenterol 2012;107:75-81.
40. Tovey ER, Willenborg CM, Crisafulli DA, et al. Most personal exposure to house dust mite aeroallergen occurs during the day. PLoS ONE 2013;8:e69900.
41. Korsgaard J. House-dust mites and asthma. A review on house-dust mites as a domestic risk factor for mite asthma. Allergy 1998;53:77-83.
42. Korsgaard J. Epidemiology of house-dust mites. Allergy 1998;53:36-40.